Back to calendar
NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NAMS reports earnings on Wednesday, November 11, 2026
earnings report
November 11, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.50
Actual EPS: $-0.52
Company overview
Market Cap$3.0B
SectorHealth Technology
IndustryPharmaceuticals: Major